FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1562815879> ?p ?o ?g. }

• W1562815879 endingPage "23" @default.
• W1562815879 startingPage "3415" @default.
• W1562815879 abstract "The purpose of our study was to develop a pharmacokinetic model to quantify the intracellular 5-fluorouracil (5-FU) concentration in liver metastases, which is expected to be closely correlated to therapy response. In addition, the influence of the biomodulator folinic acid on the action of 5-FU in the metastases was investigated. After i.v. application of 5-FU labeled with the positron emitter fluorine-18 (5-[18F]FU), the kinetics of the regional 5-[18F]FU/uptake was measured dynamically with positron emission tomography over 120 min in 14 patients with a total of 27 liver metastases from colorectal adenocarcinoma. Activity-time curves were evaluated in the metastases, the normal liver tissue, as well as in the aorta and analyzed by a six-compartment model. The catabolic breakdown of 5-FU to alpha-fluoro-beta-alanine (FBAL) in the normal liver tissue was modeled to separate the catabolites from the cytostatic agent 5-[18F]FU and the active 5-[18F]fluorodeoxyuridine nucleotides. With our model, all measured activity-time courses could be described adequately with only small interindividual variations in parameters connected with liver and blood. Extrahepatic clearance of 5-FU was estimated as 0.66 +/- 0.33 liters/min, whereas the hepatic clearance was 0.52 +/- 0.25 liters/min. The Michaelis-Menten parameters describing the nonlinear conversion of 5-FU to FBAL were Km = 11.3 +/- 6.4 micromol and Vmax = 147.1 +/- 130.7 micromol/min. The maximum FBAL concentration in the liver was reached between 35 and 65 min after i.v. 5-FU infusion. The most sensitive parameters for therapy monitoring were k(in) and k(out), which characterize the transport in and out of the intracellular volume of the metastases, respectively. Tumor response can only be expected if k(in) is high and k(out) is low (trapping). These criteria were met by 6 of the 27 metastases, which were identical to those with high values for the area under the intracellular 5-FU concentration curve (AUC[meta,IC]5-FU). The parameters k(in) and k(out) were also used to investigate the influence of the biomodulating agent folinic acid on drug effect. Five of the six metastases that showed trapping belonged to patients who received folinic acid. With the exception of one patient, however, all patients who received folinic acid had multiple metastases, of which only one was able to trap 5-FU. Because patient response can only be expected when all metastases trap 5-FU, folinic acid showed no effect on the overall clinical response. With the quantitative modeling approach used, trapping of 5-FU can be assessed noninvasively and on an individual basis. This makes it possible to adjust the dose for each individual patient to optimize the treatment schedule." @default.
• W1562815879 created "2016-06-24" @default.
• W1562815879 creator A5008622761 @default.
• W1562815879 creator A5023362414 @default.
• W1562815879 creator A5026237198 @default.
• W1562815879 creator A5028261654 @default.
• W1562815879 creator A5073940993 @default.
• W1562815879 creator A5074737687 @default.
• W1562815879 creator A5079653633 @default.
• W1562815879 creator A5087307905 @default.
• W1562815879 date "1997-08-15" @default.
• W1562815879 modified "2023-09-23" @default.
• W1562815879 title "Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma." @default.
• W1562815879 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9270007" @default.
• W1562815879 hasPublicationYear "1997" @default.
• W1562815879 type Work @default.
• W1562815879 sameAs 1562815879 @default.
• W1562815879 citedByCount "28" @default.
• W1562815879 countsByYear W15628158792015 @default.
• W1562815879 countsByYear W15628158792016 @default.
• W1562815879 crossrefType "journal-article" @default.
• W1562815879 hasAuthorship W1562815879A5008622761 @default.
• W1562815879 hasAuthorship W1562815879A5023362414 @default.
• W1562815879 hasAuthorship W1562815879A5026237198 @default.
• W1562815879 hasAuthorship W1562815879A5028261654 @default.
• W1562815879 hasAuthorship W1562815879A5073940993 @default.
• W1562815879 hasAuthorship W1562815879A5074737687 @default.
• W1562815879 hasAuthorship W1562815879A5079653633 @default.
• W1562815879 hasAuthorship W1562815879A5087307905 @default.
• W1562815879 hasConcept C112705442 @default.
• W1562815879 hasConcept C121332964 @default.
• W1562815879 hasConcept C121608353 @default.
• W1562815879 hasConcept C126322002 @default.
• W1562815879 hasConcept C147120987 @default.
• W1562815879 hasConcept C185592680 @default.
• W1562815879 hasConcept C202100949 @default.
• W1562815879 hasConcept C2775842073 @default.
• W1562815879 hasConcept C2776694085 @default.
• W1562815879 hasConcept C2779804826 @default.
• W1562815879 hasConcept C2780456651 @default.
• W1562815879 hasConcept C2781182431 @default.
• W1562815879 hasConcept C2989005 @default.
• W1562815879 hasConcept C62520636 @default.
• W1562815879 hasConcept C71924100 @default.
• W1562815879 hasConceptScore W1562815879C112705442 @default.
• W1562815879 hasConceptScore W1562815879C121332964 @default.
• W1562815879 hasConceptScore W1562815879C121608353 @default.
• W1562815879 hasConceptScore W1562815879C126322002 @default.
• W1562815879 hasConceptScore W1562815879C147120987 @default.
• W1562815879 hasConceptScore W1562815879C185592680 @default.
• W1562815879 hasConceptScore W1562815879C202100949 @default.
• W1562815879 hasConceptScore W1562815879C2775842073 @default.
• W1562815879 hasConceptScore W1562815879C2776694085 @default.
• W1562815879 hasConceptScore W1562815879C2779804826 @default.
• W1562815879 hasConceptScore W1562815879C2780456651 @default.
• W1562815879 hasConceptScore W1562815879C2781182431 @default.
• W1562815879 hasConceptScore W1562815879C2989005 @default.
• W1562815879 hasConceptScore W1562815879C62520636 @default.
• W1562815879 hasConceptScore W1562815879C71924100 @default.
• W1562815879 hasIssue "16" @default.
• W1562815879 hasLocation W15628158791 @default.
• W1562815879 hasOpenAccess W1562815879 @default.
• W1562815879 hasPrimaryLocation W15628158791 @default.
• W1562815879 hasRelatedWork W1562815879 @default.
• W1562815879 hasRelatedWork W1893187277 @default.
• W1562815879 hasRelatedWork W1977541887 @default.
• W1562815879 hasRelatedWork W2028100471 @default.
• W1562815879 hasRelatedWork W2034787234 @default.
• W1562815879 hasRelatedWork W2075570718 @default.
• W1562815879 hasRelatedWork W2095213650 @default.
• W1562815879 hasRelatedWork W2409000725 @default.
• W1562815879 hasRelatedWork W2433363021 @default.
• W1562815879 hasRelatedWork W2413516421 @default.
• W1562815879 hasVolume "57" @default.
• W1562815879 isParatext "false" @default.
• W1562815879 isRetracted "false" @default.
• W1562815879 magId "1562815879" @default.
• W1562815879 workType "article" @default.